The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
With what did FG convince some top professionals In their fields to come work on the future of QBTs possible success?. Being professionals what did they see or believe In FG/QBT's efforts that they believed was/Is very possible to Improve on?. Then being paid IF the SP reaches 10P?. Surely the people Involved would find employment without too much effort without any pressure or chance of failure. That's what Intrigues me. AIMO.
Probably because they see a market for their product. After all plenty of Pharmas working on producing new compounds all the time. So you can soon fall behind. It's a long long time since SHs were to be rewarded. Are SHs being kidded along. It's hard to believe so with Pension Funds etc Invested . It is getting tiresome though. AIMO.
Yes ~Chester your No 1 point re Redmile/Vulpus. Is the only reason we are at the high of 11p and not a lot lower. I made a point some years ago how fortunate Sclp and SHs were that both Redmile/Vulpus were Invested and holding.
I got some stick for referring to that fact at that time. It came from some of the Forever Investors which i never Intended to be.
Well the way I see It. There seems to be very few buyers. The more progress the Co makes the SP drops. Investors are tired waiting. Sclp are a small pharma with a Major Pipeline. A pipeline achieving VG results. Well that's what It seems like but only us already Invested over many years believe It. IMO a cheap buy out looks on the cards when you see '25/26 mentioned for some results. Maybe another reason why many Co's are leaving London for NY. AIMO.
Markku and Faron I'm sure are doing their best, but time waits on nobody. New compounds being trialed all the time. I sort of expected that some major deal buy out would have happened by now. After all Faron are well past PreClinical with very good results. Aimo.
Sorry to see it seems some frustration building. Can't blame anybody for feeling that way. As I said before you have to wonder what a Pharma has to produce to be appreciated by Investors and supported SP wise. You can see what good Presentations have done for Sclp . Even worse as I see it more presentations at year end. I just hope the're for a sort of putting It Up to Whoever Sclp maybe talking to Deal wise. Sorry but the can seems to me to be still rolling down the road. AIMO.